Latinos more vulnerable to fatty pancreas, Type 2 diabetes, study shows

September 11, 2012

Latinos are more likely to store fat in the pancreas and are less able to compensate by excreting additional insulin, a Cedars-Sinai study shows.

The research examining overweight, prediabetic patients, published online by , is part of a focus by Cedars-Sinai's Heart Institute, Biomedical Imaging Research Institute and and Obesity Research Institute, to identify biological measures that could help predict which patients are likely to develop type 2 diabetes.

"Prevention of diabetes is our goal," said Richard Bergman, PhD, director of the Cedars-Sinai Diabetes and Obesity Research Institute and a lead author on the study. "Not all people who are overweight or obese and who have go on to develop diabetes. If we can determine who is most likely to develop diabetes and why, then we can make strides toward preventing it in those individuals."

The study compared white, black and Latino participants, similarly overweight and who shared many of the same prediabetic symptoms. It found that Latinos stored fat in their pancreas, which was less able to produce adequate amounts of insulin as compared with white and black study participants. This may be why Latinos are at increased risk of developing Type 2 diabetes.

In chronic obesity, the that is designed to store fat begins to malfunction, allowing fat to spill into the pancreas, liver and skeletal muscle. Some individuals may be insulin resistant throughout their lives but never develop diabetes because their pancreas can compensate by secreting more of the metabolism-regulating hormone. In others, the pancreas cannot compensate, placing these individuals at greater risk of Type 2 diabetes.

"One of the reasons some people are at increased risk, we believe, is that fatty pancreas is unable to secrete enough insulin, which results in an individual progressing from impaired to ," said Lidia Szczepaniak, PhD, director of magnetic resonance spectroscopy at the Cedars-Sinai Heart Institute and Research Institute. "In our study, we found Latinos were especially vulnerable, as they tended to store more fat in the pancreas and their compensatory insulin secretion was entirely suppressed."

The Cedars-Sinai research, for which she was principal investigator, included use of a noninvasive medical imaging technique, known as magnetic resonance spectroscopy, to measure the amount of fat in organs.

In the study, Latino, black and white adults completed three research visits, including an oral glucose tolerance test; they took a frequently sampled intravenous glucose tolerance test to evaluate beta-cell function and insulin resistance; and they underwent to evaluate fat levels in the and liver.

According to the Centers for Disease Control and Prevention, diabetes affects 25.8 million people in the United States. An estimated 79 million Americans are prediabetic. Diabetes is the seventh leading cause of death in the United States and a major cause of heart disease and stroke.

Explore further: New inflammation hormone link may pave way to study new drugs for Type 2 diabetes

Related Stories

New inflammation hormone link may pave way to study new drugs for Type 2 diabetes

May 15, 2012
A new link between obesity and type 2 diabetes found in mice could open the door to exploring new potential drug treatments for diabetes, University of Michigan Health System research has found.

Recommended for you

Smart mat detects early warning signs of foot ulcers

August 16, 2017
While completing his residency in anesthesiology at Massachusetts General Hospital in the mid-2000s, Jon Bloom saw his fair share of foot amputations among patients with diabetes. The culprit: infected foot ulcers.

The best place to treat type 1 diabetes might be just under your skin

August 14, 2017
A group of U of T researchers have demonstrated that the space under our skin might be an optimal location to treat type 1 diabetes (T1D).

New measure of insulin-making cells could gauge diabetes progression, treatment

August 10, 2017
Researchers at the University of Wisconsin-Madison have developed a new measurement for the volume and activity of beta cells, the source of the sugar-regulating hormone insulin.

Pioneering immunotherapy shows promise in type 1 diabetes

August 9, 2017
It may be possible to 'retrain' the immune system to slow the progression of type 1 diabetes, according to results of a clinical trial published today in the journal Science Translational Medicine.

Online team-based game helps patients with diabetes lower blood glucose

August 8, 2017
Researchers from Brigham and Women's Hospital and the Veterans Affairs Boston Healthcare System have found that an online, team-based game designed to teach patients about diabetes self-management had a sustained and meaningful ...

Oxidative stress biomarkers don't always signal diabetes risk

August 7, 2017
High levels of compounds found in the body that are commonly associated with oxidative damage may actually be a good sign for some people, according to a recent review of multiple human studies led by an epidemiologist at ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.